TB Blood Test for Child Care Facilities

The Bureau of Certification is re-issuing the Bulletin: 3001-12-01, Tuberculosis Blood Test for Child Care Facilities. This bulletin was last issued February 4, 2012 and is being reissued due to a nationwide shortage of Tuberculin Skin Test Antigens; the shortage is expected to last 3-10 months. 

The purpose of this bulletin is to remind child care applicants and providers that the Interferon Gamma Release Assay (IGRA) blood test remains an acceptable replacement for the Mantoux skin test screening.  Please see the 2012 bulletin for additional information. 

Note: Comments and questions regarding this bulletin are no longer directed to Amanda Dorris. Comments and questions regarding this bulletin should be directed to Tamula Ferguson, Office of Child Development and Early Learning, Division of Regulatory Administration, Bureau of Certification, 333 Market St., 6th Floor, Harrisburg, PA 17126 or 717-346-9320.

Clarification of Medical Marijuana Within Licensed Child Care Facilities

On June 7, 2019, the Department of Human Services in conjunction with the Department of Health issued a bulletin to clarify the storage, use, and administration of medical marijuana within licensed care facilities in Pennsylvania. This bulletin can be accessed here.

Effective immediately, this bulletin applies to all family child care homes, group child care homes, and child care centers. In accordance with regulations, medications shall be stored in a locked area of the facility or in an area that is out of reach of children. Providers are prohibited from providing care to children if impaired.

COMMENTS AND QUESTIONS REGARDING THIS BULLETIN SHOULD BE DIRECTED TO : Department of Human Services Office of Policy Development, P.O. Box 2675, Harrisburg, PA 17110-2675. General Office Number 717-265-8347. You may also contact your regional Office of Child Development and Early Learning for more information .